290 related articles for article (PubMed ID: 31109699)
41. Prediction of the mechanism of miRNAs in laryngeal squamous cell carcinoma based on the miRNA-mRNA regulatory network.
Ma J; Hu X; Dai B; Wang Q; Wang H
PeerJ; 2021; 9():e12075. PubMed ID: 34513340
[TBL] [Abstract][Full Text] [Related]
42. Global miRNA Expression Profiling Identifies miR-1290 as Novel Potential oncomiR in Laryngeal Carcinoma.
Janiszewska J; Szaumkessel M; Kostrzewska-Poczekaj M; Bednarek K; Paczkowska J; Jackowska J; Grenman R; Szyfter K; Wierzbicka M; Giefing M; Jarmuz-Szymczak M
PLoS One; 2015; 10(12):e0144924. PubMed ID: 26694163
[TBL] [Abstract][Full Text] [Related]
43. Integrative analysis of mRNA and microRNA expression profiles in laryngeal squamous cell carcinoma.
Ekmekci CG; Coskunpinar E; Avci H; Farooqi AA; Orhan KS; Akbas F
J Cell Biochem; 2019 Mar; 120(3):3415-3422. PubMed ID: 30362598
[TBL] [Abstract][Full Text] [Related]
44. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
[TBL] [Abstract][Full Text] [Related]
45. RUNX3 inhibits laryngeal squamous cell carcinoma malignancy under the regulation of miR-148a-3p/DNMT1 axis.
Jili S; Eryong L; Lijuan L; Chao Z
Cell Biochem Funct; 2016 Dec; 34(8):597-605. PubMed ID: 27859417
[TBL] [Abstract][Full Text] [Related]
46. Upregulation of miR-129-5p affects laryngeal cancer cell proliferation, invasiveness, and migration by affecting STAT3 expression.
Shen N; Huang X; Li J
Tumour Biol; 2016 Feb; 37(2):1789-96. PubMed ID: 26318305
[TBL] [Abstract][Full Text] [Related]
47. Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma.
Koshizuka K; Hanazawa T; Kikkawa N; Katada K; Okato A; Arai T; Idichi T; Osako Y; Okamoto Y; Seki N
Auris Nasus Larynx; 2018 Aug; 45(4):854-865. PubMed ID: 29233721
[TBL] [Abstract][Full Text] [Related]
48. Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue.
Zhou RS; Zhang EX; Sun QF; Ye ZJ; Liu JW; Zhou DH; Tang Y
BMC Cancer; 2019 Aug; 19(1):779. PubMed ID: 31391008
[TBL] [Abstract][Full Text] [Related]
49. A pilot study reveals the potential of miR-31-3p and miR-196a-5p as non-invasive biomarkers in advanced laryngeal cancer.
Kyurkchiyan SG; Popov TM; Shakola F; Rangachev J; Mitev VI; Kaneva R
Folia Med (Plovdiv); 2021 Jun; 63(3):355-364. PubMed ID: 34196150
[TBL] [Abstract][Full Text] [Related]
50. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of microRNA expression profiling in highly metastatic laryngocarcinoma cells.
Chen L; Liu S; Li K; Qi J; Liu C; Zong L; Zhang Y; Zhao J; Zhai X; Li J; Kong X; Yang S; Liu M
Acta Otolaryngol; 2018 Dec; 138(12):1105-1111. PubMed ID: 30702035
[TBL] [Abstract][Full Text] [Related]
52. Comprehensive expression profiling of microRNAs in laryngeal squamous cell carcinoma.
Cao P; Zhou L; Zhang J; Zheng F; Wang H; Ma D; Tian J
Head Neck; 2013 May; 35(5):720-8. PubMed ID: 22605671
[TBL] [Abstract][Full Text] [Related]
53. MicroRNA-34c-5p is related to recurrence in laryngeal squamous cell carcinoma.
Re M; Çeka A; Rubini C; Ferrante L; Zizzi A; Gioacchini FM; Tulli M; Spazzafumo L; Sellari-Franceschini S; Procopio AD; Olivieri F
Laryngoscope; 2015 Sep; 125(9):E306-12. PubMed ID: 26153151
[TBL] [Abstract][Full Text] [Related]
54. HOX genes: potential candidates for the progression of laryngeal squamous cell carcinoma.
de Barros E Lima Bueno R; Ramão A; Pinheiro DG; Alves CP; Kannen V; Jungbluth AA; de Araújo LF; Muys BR; Fonseca AS; Plaça JR; Panepucci RA; Neder L; Saggioro FP; Mamede RC; Figueiredo DL; Silva WA
Tumour Biol; 2016 Nov; 37(11):15087-15096. PubMed ID: 27658780
[TBL] [Abstract][Full Text] [Related]
55. miR-370 targeted FoxM1 functions as a tumor suppressor in laryngeal squamous cell carcinoma (LSCC).
Yungang W; Xiaoyu L; Pang T; Wenming L; Pan X
Biomed Pharmacother; 2014 Mar; 68(2):149-54. PubMed ID: 24055400
[TBL] [Abstract][Full Text] [Related]
56. Screening key miRNAs for human hepatocellular carcinoma based on miRNA-mRNA functional synergistic network.
Zhang CJ; Du HJ
Neoplasma; 2017; 64(6):816-823. PubMed ID: 28895405
[TBL] [Abstract][Full Text] [Related]
57. Identification of Critical miRNAs as Novel Diagnostic Markers for Laryngeal Squamous Cell Carcinoma.
Luo K; Zhao Y; Liu H; Mo J
Dis Markers; 2022; 2022():6858411. PubMed ID: 35909889
[TBL] [Abstract][Full Text] [Related]
58. miR-140-5p targeted FGF9 and inhibited the cell growth of laryngeal squamous cell carcinoma.
Wang Y; Huang Q; Li F
Biochem Cell Biol; 2020 Apr; 98(2):83-89. PubMed ID: 31867983
[TBL] [Abstract][Full Text] [Related]
59. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
[TBL] [Abstract][Full Text] [Related]
60. MicroRNA-101 regulates autophagy, proliferation and apoptosis via targeting EZH2 in laryngeal squamous cell carcinoma.
Chen L; Jia J; Zang Y; Li J; Wan B
Neoplasma; 2019 Jul; 66(4):507-515. PubMed ID: 30868890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
